ARCHIVED Graphic Version PDF Version To Publications Page To Home Page
Title:
National Drug Threat Assessment 2006
Publication Date: January 2006
Document ID: 2006-Q0317-001
Archived on: July 1, 2009. This document may contain dated information. It remains available to provide access to historical materials.
This assessment addresses the status and outlook of the drug threat to the United States. It covers the trafficking and abuse patterns of cocaine, methamphetamine, marijuana, heroin, MDMA, pharmaceutical drugs, and other dangerous drugs.
Your questions, comments, and suggestions for future subjects are welcome at any time. Addresses are provided at the end of the page.
Contents
Strategic Drug Threat Developments
Cocaine
Strategic Findings
Overview
Availability
Production
Transportation
Distribution
DemandMethamphetamine
Strategic Findings
Overview
Availability
Production
Transportation
Distribution
DemandMarijuana
Strategic Findings
Overview
Availability
Production
Transportation
Distribution
DemandHeroin
Strategic Findings
Overview
Availability
Production
Transportation
Distribution
DemandPharmaceuticals
Strategic Findings
Overview
Availability
Diversion and Distribution
AbuseOther Dangerous Drugs
Strategic Findings
Overview
MDMA
GHB
LSD
PCPDrug Money Laundering
Strategic Findings
Drug Transportation Corridors
Drug Trafficking Organizations
Organized Gangs and Drug Trafficking
The Impact of Drugs on SocietyList of Maps
Appendix A
Map 1. Seven Regions
Map 2. National Drug Threat Survey 2005 greatest drug threat as reported by state and local agencies.
Map 3. Areas of influence of drug trafficking organizations in the United States.
Map 4. Methamphetamine threat progression.
Map 5. Vectors in the Transit Zone--CCDB-documented cocaine flow departing South America, January-December 2004.
Map 6. Principal drug distribution centers.List of Tables
Table 1. Estimated Andean Region Coca Cultivation and Potential Pure Cocaine Production, 2000-2004
Table 2. Cocaine Lost or Seized in Transit Toward the United States in Metric Tons, 2000-2004
Table 3. Cocaine Available to U.S. Markets in Metric Tons, 2004
Table 4. Reported Methamphetamine Laboratory Seizures, 1997-2005
Table 5. Mexico: Marijuana Cultivation and Production, 2000-2004
Table 6. Domestic Cannabis Eradication, Outdoor and Indoor Plant Seizures, 2000-2005
Table 7. U.S. Arrival Zone Seizures of Marijuana, in Kilograms, 2001-2004
Table 8. Potential Worldwide Heroin Productions, in Metric Tons, 1999-2005
Table 9. South American Heroin Seizures for New York and Miami Ports of Entry in Kilograms, 2003-2004
Table 10. Principal Heroin Ports of Entry Seizures, In Kilograms, 2003-2004
Table 11. Number of Heroin Seizures at Air, Land, and Maritime Ports of Entry, 2004Appendix B:
Table 1. NSDUH Trends in Percentage of Past Year Drug Use, 2002-2004
Table 2. MTF Adolescent Trends in Percentage of Past Year Drug Use, 2000-2005
Table 3. Federal-Wide Drug Seizures, in Kilograms, 2000-2004
Table 4. Drug-Related Arrests, United States, 2000-2004
Table 5. Other Dangerous Drugs Submitted for Testing in the United States, in Dosage Units, 2000-2005
Table 6. Average Purity of Drug Samples Tested, Percentage, 2001-2004List of Figures
Figure 1. Average percentage of THC in samples of seized marijuana, 1985-2005
Figure 2. Top 10 National Forests for eradication of cannabis on Forest Service lands in 2004.
Figure 3. Commercial disbursements of commonly abused pharmaceuticals, United States, 2000-2004.
Figure 4. Drug Corridors in the United StatesAppendix C
Chart 1. TEDS Treatment Admissions, 1993-2003
Chart 2. Central States Methamphetamine Laboratory Seizures, 2000-2004
From the Director
Drug trafficking and drug abuse continue to pose a significant threat to the citizens of the United States and an ever-increasing challenge to law enforcement and drug treatment personnel. To develop an effective counterdrug strategy, policymakers and law enforcement leadership require both tactical and strategic intelligence regarding national and regional drug trafficking. The National Drug Intelligence Center's annual threat assessment is designed to provide these decisionmakers with the timely, strategic, drug-related intelligence needed to effectively formulate counterdrug policy, establish law enforcement priorities, and allocate resources.
The 2006 National Drug Threat Assessment is similar in many respects to previous editions of the annual assessment; however, reader feedback and comments from client and partner agencies have prompted some significant changes. The 2006 National Drug Threat Assessment is more succinct than previous assessments in its analysis and presentation of key drug trafficking trends and developments. The 2006 assessment also offers more predictive insight regarding potential areas of concern for counterdrug policymakers in the near term.
The National Drug Intelligence Center is in the midst of a strategic reorganization designed to further enhance its ability to provide timely, focused, and increasingly useful strategic intelligence products to national-level policymakers, resource planners, and law enforcement and intelligence community leaders. Further enhancements will be made to our 2007 National Drug Threat Assessment to reflect the efficiencies gained from this strategic reorganization.
As in past years, the 2006 National Drug Threat Assessment is the outgrowth of a partnership between the National Drug Intelligence Center and countless other federal, state, and local agencies. The report merges the most current data and reporting from law enforcement, intelligence agencies, and public health agencies with the National Drug Intelligence Center's own national survey of more than 3,400 state and local law enforcement agencies and thousands of field interviews with law enforcement and public health officials.
Thanks to all the participating agencies and organizations whose contributions have made the 2006 National Drug Threat Assessment possible. Their assistance has been invaluable!
Michael F. Walther
January 2006
Addresses
National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901Tel. (814) 532-4601
FAX (814) 532-4690
Email NDIC.Contacts@usdoj.govNational Drug Intelligence Center
8201 Greensboro Drive, Suite 1001
McLean, VA 22102-3840Tel. (703) 556-8970
FAX (703) 556-7807
Web Addresses
ADNET: http://ndicosa
DOJ: http://www.usdoj.gov/archive/ndic/
LEO: home.leo.gov/lesig/archive/ndic/
To Top To Contents To Next Page
To Publications Page To Home Page
End of page.